[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-07 Prognostic biomarkers,,"},{"Key":"Keywords","Value":"Bladder cancer,Prognosis,DNA methylation,Urine,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>P. Piatti<\/b><sup>1<\/sup>, S. Daneshmand<sup>2<\/sup>, S. L. Seyedian<sup>3<\/sup>, S. Ghodossipour<sup>4<\/sup>, H. Ahmadi<sup>5<\/sup>, S. Roberts<sup>2<\/sup>, A. Ghoreifi<sup>2<\/sup>, M. Basin<sup>6<\/sup>, S. Hajian<sup>2<\/sup>, Y. Chew<sup>7<\/sup>, J. Bhasin<sup>1<\/sup>, B. Jara<sup>7<\/sup>, L. Sanossian<sup>7<\/sup>, H. Djaladat<sup>2<\/sup>, A. Shuckman<sup>2<\/sup>, S. Bhavandia<sup>2<\/sup>, G. Liang<sup>2<\/sup>; <br\/><sup>1<\/sup>Zymo Research Corp., Irvine, CA, <sup>2<\/sup>University of Southern California, Los Angeles, CA, <sup>3<\/sup>Vanderbilt University, Nashville, TN, <sup>4<\/sup>Rutgers Cancer Institute, NewBrunswick, NJ, <sup>5<\/sup>M Health Fairview Southdale Hospital, Minneapolis, MN, <sup>6<\/sup>SUNY Upstate University Hospital, Syracuse, NY, <sup>7<\/sup>Pangea Laboratory, LLC, Tustin, CA","CSlideId":"","ControlKey":"4aa80b5e-a392-470d-842d-7ca9fc23a1ae","ControlNumber":"10842","DisclosureBlock":"<b>&nbsp;P. Piatti, <\/b> <br><b>Zymo Research Corporation<\/b> Employment. <br><b>Pangea Laboratory, LLC<\/b> Independent Contractor.<br><b>S. Daneshmand, <\/b> None..<br><b>S. L. Seyedian, <\/b> None..<br><b>S. Ghodossipour, <\/b> None..<br><b>H. Ahmadi, <\/b> None..<br><b>S. Roberts, <\/b> None..<br><b>A. Ghoreifi, <\/b> None..<br><b>M. Basin, <\/b> None..<br><b>S. Hajian, <\/b> None.&nbsp;<br><b>Y. Chew, <\/b> <br><b>Pangea Laboratory<\/b> Employment. <br><b>Zymo Research Corporation<\/b> Employment. <br><b>J. Bhasin, <\/b> <br><b>Zymo Research Corporation<\/b> Employment. <br><b>B. Jara, <\/b> <br><b>Pangea Laboratory, LLC<\/b> Employment. <br><b>L. Sanossian, <\/b> <br><b>Pangea Laboratory, LLC<\/b> Employment.<br><b>H. Djaladat, <\/b> None..<br><b>A. Shuckman, <\/b> None..<br><b>S. Bhavandia, <\/b> None..<br><b>G. Liang, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10403","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB327","PresenterBiography":null,"PresenterDisplayName":"Paolo Piatti, PhD","PresenterKey":"19ff73aa-e64a-4bf4-9158-7621b725cb8b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB327. DNA methylation biomarkers for early bladder cancer detection and treatment response monitoring","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"DNA methylation biomarkers for early bladder cancer detection and treatment response monitoring","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-07 Prognostic biomarkers,,"},{"Key":"Keywords","Value":"Breast,Estrogen receptor,Image analysis,Biopsies,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>M. L. Stallings-Mann<\/b><sup>1<\/sup>, R. A. Vierkant<sup>2<\/sup>, S. J. Winham<sup>2<\/sup>, B. McCauley<sup>2<\/sup>, M. R. Jensen<sup>2<\/sup>, S. Noel<sup>1<\/sup>, L. Pacheco-Spann<sup>1<\/sup>, C. M. Vachon<sup>2<\/sup>, A. C. Degnim<sup>2<\/sup>, D. C. Radisky<sup>1<\/sup>, M. E. Sherman<sup>1<\/sup>; <br\/><sup>1<\/sup>Mayo Clinic Florida, Jacksonville, FL, <sup>2<\/sup>Mayo Clinic, Rochester, MN","CSlideId":"","ControlKey":"3eabc92e-66e4-45eb-8564-a86e4bf4a45f","ControlNumber":"10757","DisclosureBlock":"&nbsp;<b>M. L. Stallings-Mann, <\/b> None..<br><b>R. A. Vierkant, <\/b> None..<br><b>S. J. Winham, <\/b> None..<br><b>B. McCauley, <\/b> None..<br><b>M. R. Jensen, <\/b> None..<br><b>S. Noel, <\/b> None..<br><b>L. Pacheco-Spann, <\/b> None..<br><b>C. M. Vachon, <\/b> None..<br><b>A. C. Degnim, <\/b> None..<br><b>D. C. Radisky, <\/b> None..<br><b>M. E. Sherman, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10405","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"2","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB328","PresenterBiography":null,"PresenterDisplayName":"Melody Stallings-Mann, PhD","PresenterKey":"cf9d41ca-e6a9-46e7-be12-7606efe52864","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB328. Measurement of ER and Ki67 coexpression in cytokeratin positive epithelial cells in benign breast disease (BBD) percutaneous biopsies","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Measurement of ER and Ki67 coexpression in cytokeratin positive epithelial cells in benign breast disease (BBD) percutaneous biopsies","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-07 Prognostic biomarkers,,"},{"Key":"Keywords","Value":"Interleukin-6,Oral cancers,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>H. Goda<\/b>, T. Adachi, K.-i. Nakashiro, N. Kuribayashi, D. Uchida; <br\/>Ehime Univ. Graduate School of Medicine, Toon, Japan","CSlideId":"","ControlKey":"b7d41016-dfc0-421c-8e14-d853581300e7","ControlNumber":"10522","DisclosureBlock":"&nbsp;<b>H. Goda, <\/b> None..<br><b>T. Adachi, <\/b> None..<br><b>K. Nakashiro, <\/b> None..<br><b>N. Kuribayashi, <\/b> None..<br><b>D. Uchida, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10406","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB329","PresenterBiography":null,"PresenterDisplayName":"Hiroyuki Goda","PresenterKey":"680dc859-2af7-4310-9baa-c26c2be10ca0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB329. Interleukin6 as a Potential Prognostic Marker and Therapeutic Target in Oral Squamous Cell Carcinoma","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Interleukin6 as a Potential Prognostic Marker and Therapeutic Target in Oral Squamous Cell Carcinoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-07 Prognostic biomarkers,,"},{"Key":"Keywords","Value":"Colorectal cancer,CWH43,Biomarkers,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Cheng-Chin Lee<\/b><sup>1<\/sup>, Yu-Jia Chang<sup>1<\/sup>, Chien-Yu Huang<sup>2<\/sup><br><br\/><sup>1<\/sup>Taipei Medical University, Taipei, Taiwan,<sup>2<\/sup>National Tsing Hua University, Hsinchu, Taiwan","CSlideId":"","ControlKey":"21b6479a-beed-483b-a084-d16df5e1b21c","ControlNumber":"10536","DisclosureBlock":"&nbsp;<b>C. Lee, <\/b> None..<br><b>Y. Chang, <\/b> None..<br><b>C. Huang, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10407","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB330","PresenterBiography":null,"PresenterDisplayName":"Cheng-Chin Lee, Graduate Student","PresenterKey":"8f105411-6ec6-4d4d-9367-8a0f2fc036a7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB330. CWH43 as a prognostic marker and therapeutic target in colorectal cancer","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"CWH43 as a prognostic marker and therapeutic target in colorectal cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-08 Spatial proteomics and transcriptomics,,"},{"Key":"Keywords","Value":"Tumor microenvironment,Immune cells,Solid tumors,Multiomics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>C. Price<\/b>, K. Nishimura, S. Bandyopadhyay, D. Borger, R. Weiner; <br\/>Takeda Pharmaceutical Company Ltd. (U.S.), Cambridge, MA","CSlideId":"","ControlKey":"fb1af8f1-e212-4607-8cd4-5154dca29670","ControlNumber":"10899","DisclosureBlock":"&nbsp;<b>C. Price, <\/b> None..<br><b>K. Nishimura, <\/b> None..<br><b>S. Bandyopadhyay, <\/b> None..<br><b>D. Borger, <\/b> None..<br><b>R. Weiner, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10408","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"5","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB331","PresenterBiography":null,"PresenterDisplayName":"Colles Price, MS;PhD","PresenterKey":"020f1c8d-cb18-4b26-bc00-6e10b66a120a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB331. Integrating multiple spatial transcriptomic and proteomic technologies to generate a cancer atlas to understand the tumor microenvironment","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Integrating multiple spatial transcriptomic and proteomic technologies to generate a cancer atlas to understand the tumor microenvironment","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-08 Spatial proteomics and transcriptomics,,"},{"Key":"Keywords","Value":"Glioblastoma,Slow Cycling Cells,Spatial transcriptomic and proteomic,Metabolism,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Chakraborty<\/b>, D. Feier, A. Silver, C. Yang, M. Anica, A. Pittu, O. Sobanjo, E. Hodge, M. Engelbart, C. Von Roemeling, M. Rahman, M. Sarkisian, J. Huang, J. Harrison, D. Mitchell, L. Deleyrolle; <br\/>University of Florida, Gainesville, FL","CSlideId":"","ControlKey":"fb3dc311-04b0-4a65-a513-a60c123dcdd0","ControlNumber":"10463","DisclosureBlock":"&nbsp;<b>A. Chakraborty, <\/b> None..<br><b>D. Feier, <\/b> None..<br><b>A. Silver, <\/b> None..<br><b>C. Yang, <\/b> None..<br><b>M. Anica, <\/b> None..<br><b>A. Pittu, <\/b> None..<br><b>O. Sobanjo, <\/b> None..<br><b>E. Hodge, <\/b> None..<br><b>M. Engelbart, <\/b> None..<br><b>C. Von Roemeling, <\/b> None..<br><b>M. Rahman, <\/b> None..<br><b>M. Sarkisian, <\/b> None..<br><b>J. Huang, <\/b> None..<br><b>J. Harrison, <\/b> None..<br><b>D. Mitchell, <\/b> None..<br><b>L. Deleyrolle, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10409","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"6","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB332","PresenterBiography":null,"PresenterDisplayName":"Avirup Chakraborty","PresenterKey":"d8d8d88c-bfc6-44cd-bb33-88e219baa865","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB332. Spatial transcriptomic and proteomic analysis of the treatment resistant slow cycling micro environment in GBM","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Spatial transcriptomic and proteomic analysis of the treatment resistant slow cycling micro environment in GBM","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL01-08 Spatial proteomics and transcriptomics,,"},{"Key":"Keywords","Value":"Image analysis,FFPE,Gene expression analysis,Multiomics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"Jiang He<sup><\/sup>, Bin Wang<sup><\/sup>, Justin He<sup><\/sup>, Renchao Chen<sup><\/sup>, Benjamin Patterson<sup><\/sup>, Sudhir Tattikota<sup><\/sup>, Timothy Wiggin<sup><\/sup>, Lizi Maziashvili<sup><\/sup>, Peter Reinhold<sup><\/sup>, Manisha Ray<sup><\/sup>, <b>George Emanuel<\/b><sup><\/sup><br><br\/>Vizgen, Cambridge, MA","CSlideId":"","ControlKey":"46929578-b6bf-4b75-8124-1055c7f75923","ControlNumber":"10471","DisclosureBlock":"&nbsp;<b>J. He, <\/b> None..<br><b>B. Wang, <\/b> None..<br><b>J. He, <\/b> None..<br><b>R. Chen, <\/b> None..<br><b>B. Patterson, <\/b> None..<br><b>S. Tattikota, <\/b> None..<br><b>T. Wiggin, <\/b> None..<br><b>L. Maziashvili, <\/b> None..<br><b>P. Reinhold, <\/b> None..<br><b>M. Ray, <\/b> None.&nbsp;<br><b>G. Emanuel, <\/b> <br><b>Vizgen<\/b> Employment, Other, Co-founder.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10410","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB333","PresenterBiography":null,"PresenterDisplayName":"George Emanuel, PhD","PresenterKey":"d6b0526b-2c25-4fc9-9947-e1635dd6b0a2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB333. Improved spatially resolved single-cell transcriptomic imaging in archival tissues with MERSCOPE","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Improved spatially resolved single-cell transcriptomic imaging in archival tissues with MERSCOPE","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL03-08 Preclinical studies of endocrine-related cancers,,"},{"Key":"Keywords","Value":"Breast cancer,CYP3A4,biguanide,epoxyeicosatrienoic acids (EETs),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Z. Guo<\/b><sup>1<\/sup>, J. Lei<sup>1<\/sup>, A. Makovec<sup>1<\/sup>, S. Jayaraman<sup>2<\/sup>, J. R. Hawse<sup>2<\/sup>, C. Lange<sup>1<\/sup>, E. Ambrose<sup>1<\/sup>, G. I. Georg<sup>1<\/sup>, T. D'Assoro<sup>2<\/sup>, G. P. Matthew<sup>2<\/sup>, D. A. Potter<sup>1<\/sup>; <br\/><sup>1<\/sup>University of Minnesota, Minneapolis, MN, <sup>2<\/sup>Mayo Clinic, Rochester, MN","CSlideId":"","ControlKey":"f4c8557e-b7cb-43df-b88d-01767d43e521","ControlNumber":"10788","DisclosureBlock":"&nbsp;<b>Z. Guo, <\/b> None..<br><b>J. Lei, <\/b> None..<br><b>A. Makovec, <\/b> None..<br><b>S. Jayaraman, <\/b> None..<br><b>J. R. Hawse, <\/b> None..<br><b>C. Lange, <\/b> None..<br><b>E. Ambrose, <\/b> None..<br><b>G. I. Georg, <\/b> None..<br><b>T. D'Assoro, <\/b> None..<br><b>G. P. Matthew, <\/b> None..<br><b>D. A. Potter, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10411","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB334","PresenterBiography":null,"PresenterDisplayName":"Zhijun Guo, PhD","PresenterKey":"29855a69-e926-4f12-a51c-e81c38707de5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB334. Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL03-10 Steroid hormone receptors,,"},{"Key":"Keywords","Value":"Breast cancer,Steroid hormones,Antiestrogens,Molecular markers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Azadova<\/b>, G. Brooke, A. Marco; <br\/>University of Essex, Colchester, United Kingdom","CSlideId":"","ControlKey":"6c3ecc89-d6fa-4e23-be70-867201da68c6","ControlNumber":"9754","DisclosureBlock":"&nbsp;<b>A. Azadova, <\/b> None..<br><b>G. Brooke, <\/b> None..<br><b>A. Marco, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10412","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"9","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB335","PresenterBiography":null,"PresenterDisplayName":"Aygun Azadova, PhD","PresenterKey":"608a862d-f970-4d1f-bb06-44e251170eba","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB335. Steroid receptor cross-talk in breast cancer","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Steroid receptor cross-talk in breast cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL05-01 Biobanking\/biospecimen collection,,"},{"Key":"Keywords","Value":"Biobank,Sequencing,Biomarkers,Somatic mutations,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Bediako<\/b>, J. Ngoi, R. Kiome, S. Agyemang, S. Darkoh, Jr., A. Lemacon, A. Manu, F. Onyambu, K. Diallo, L. Paemka, D. Hutchful, E. Amoako, A. Diallo; <br\/>Yemaachi Biotech Ltd., Accra, Ghana","CSlideId":"","ControlKey":"9dc2261e-918d-4fb1-bc6f-72130f69ad24","ControlNumber":"10498","DisclosureBlock":"&nbsp;<b>Y. Bediako, <\/b> None..<br><b>J. Ngoi, <\/b> None..<br><b>R. Kiome, <\/b> None..<br><b>S. Agyemang, <\/b> None..<br><b>S. Darkoh, <\/b> None..<br><b>A. Lemacon, <\/b> None..<br><b>A. Manu, <\/b> None..<br><b>F. Onyambu, <\/b> None..<br><b>K. Diallo, <\/b> None..<br><b>L. Paemka, <\/b> None..<br><b>D. Hutchful, <\/b> None..<br><b>E. Amoako, <\/b> None..<br><b>A. Diallo, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10413","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"10","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB336","PresenterBiography":null,"PresenterDisplayName":"Yaw Bediako, PhD","PresenterKey":"a1d180e6-51eb-4e95-89e7-596592b65ae3","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB336. The African Cancer Atlas: Leveraging African data to diversify precision oncology","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The African Cancer Atlas: Leveraging African data to diversify precision oncology","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"Macrophages,Adoptive cell therapy,Melanoma\/skin cancers,Immune checkpoint blockade,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Kim<\/b><sup>1<\/sup>, T.-J. Kim<sup>2<\/sup>, S. Chae<sup>3<\/sup>, H. Ha<sup>1<\/sup>, Y. Park<sup>1<\/sup>, S. Lim<sup>4<\/sup>, H. Lee<sup>1<\/sup>, Y. Sim<sup>1<\/sup>, S. Oh<sup>1<\/sup>, G. Koo<sup>1<\/sup>, M. Jo<sup>1<\/sup>, D. Hwang<sup>5<\/sup>, K.-M. Lee<sup>1<\/sup>; <br\/><sup>1<\/sup>Korea University, Seoul, Korea, Republic of, <sup>2<\/sup>Korea Institute of Radiological and Medical Sciences (KIRMS), Seoul, Korea, Republic of, <sup>3<\/sup>Korea Brain Research Institute (KBRI), Daegu, Korea, Republic of, <sup>4<\/sup>Ewha Womans University, Seoul, Korea, Republic of, <sup>5<\/sup>Seoul National University, Seoul, Korea, Republic of","CSlideId":"","ControlKey":"fee789ee-14ef-4084-be07-06063ab78adc","ControlNumber":"9524","DisclosureBlock":"&nbsp;<b>J. Kim, <\/b> None..<br><b>T. Kim, <\/b> None..<br><b>S. Chae, <\/b> None..<br><b>H. Ha, <\/b> None..<br><b>Y. Park, <\/b> None..<br><b>S. Lim, <\/b> None..<br><b>H. Lee, <\/b> None..<br><b>Y. Sim, <\/b> None..<br><b>S. Oh, <\/b> None..<br><b>G. Koo, <\/b> None..<br><b>M. Jo, <\/b> None..<br><b>D. Hwang, <\/b> None..<br><b>K. Lee, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10415","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB338","PresenterBiography":null,"PresenterDisplayName":"Jeongsoo Kim","PresenterKey":"ce647d70-9a1e-40ff-9077-670c5f4ce616","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB338. Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"EZH2,Immunotherapy,T cell,Epigenetics,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Hou<\/b>, P. Wu; <br\/>The Scripps Research Institute, San Diego, CA","CSlideId":"","ControlKey":"324e950a-deb7-4e2a-837a-bf92e4bb4dcc","ControlNumber":"10252","DisclosureBlock":"&nbsp;<b>Y. Hou, <\/b> None..<br><b>P. Wu, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10416","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB339","PresenterBiography":null,"PresenterDisplayName":"Yingqin Hou, PhD","PresenterKey":"5d49252a-2537-4ef5-ad29-e58a595ce753","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB339. Transient EZH2 suppression by tazemetostat during <i>in vitro<\/i> expansion maintains T cell stemness and improves adoptive T cell therapy","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Transient EZH2 suppression by tazemetostat during <i>in vitro<\/i> expansion maintains T cell stemness and improves adoptive T cell therapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"Adoptive immunotherapy,Preclinical,CAR T cells,Endogenous Retrovirus,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. M. Lehar<\/b>, S. Roy, L. Liao, H. Chen, Y. Chen, M. Cruz Tleugabulova, E. Janezic, A. Madjidi, T. Jones, V. Javinal, J. Ziai, I. Mellman, J. Schartner, A. Shaw; <br\/>Genentech, South San Francisco, CA","CSlideId":"","ControlKey":"5303a4d5-b77f-434a-9de2-f8b90f9054ff","ControlNumber":"10302","DisclosureBlock":"<b>&nbsp;S. M. Lehar, <\/b> <br><b>Genentech<\/b> Employment.<br><b>S. Roy, <\/b> None.&nbsp;<br><b>L. Liao, <\/b> <br><b>Genentech<\/b> Employment.<br><b>H. Chen, <\/b> None.&nbsp;<br><b>Y. Chen, <\/b> <br><b>Genentech<\/b> Employment. <br><b>M. Cruz Tleugabulova, <\/b> <br><b>Genentech<\/b> Employment. <br><b>E. Janezic, <\/b> <br><b>Genentech<\/b> Employment.<br><b>A. Madjidi, <\/b> None.&nbsp;<br><b>T. Jones, <\/b> <br><b>Genentech<\/b> Employment. <br><b>V. Javinal, <\/b> <br><b>Genentech<\/b> Employment. <br><b>J. Ziai, <\/b> <br><b>Genentech<\/b> Employment. <br><b>I. Mellman, <\/b> <br><b>Genentech<\/b> Employment. <br><b>J. Schartner, <\/b> <br><b>Genentech<\/b> Employment. <br><b>A. Shaw, <\/b> <br><b>Genentech<\/b> Employment.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10417","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB340","PresenterBiography":null,"PresenterDisplayName":"Sophie Lehar","PresenterKey":"096eb78e-ef3b-494d-bd53-6479329963a5","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB340. Harnessing the gp70 endogenous retrovirus envelope protein as a universal tumor antigen for T cell therapy in mice","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Harnessing the gp70 endogenous retrovirus envelope protein as a universal tumor antigen for T cell therapy in mice","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"Adoptive cell therapy,CAR T cells,Leukemias: acute lymphoblastic,RNA sequencing (RNA-Seq),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Li<\/b><sup>1<\/sup>, L. Xue<sup>2<\/sup>, S. Li<sup>2<\/sup>, L. He<sup>1<\/sup>, K. Liu<sup>1<\/sup>, R. Jin<sup>1<\/sup>, T. Wang<sup>1<\/sup>, Y. Zhang<sup>1<\/sup>, S. Chen<sup>1<\/sup>, Y. Gao<sup>1<\/sup>, D. Liu<sup>1<\/sup>, L. Yang<sup>1<\/sup>, X. Wang<sup>2<\/sup>; <br\/><sup>1<\/sup>Fundamenta Therapeutics Co,.Ltd, Suzhou, Jiangsu, China, <sup>2<\/sup>The First Affiliated Hospital of USTC, Anhui, Hefei, China","CSlideId":"","ControlKey":"2a604fd1-7138-4fdb-a36d-9c37cc1b6d59","ControlNumber":"10604","DisclosureBlock":"&nbsp;<b>J. Li, <\/b> None..<br><b>L. Xue, <\/b> None..<br><b>S. Li, <\/b> None..<br><b>L. He, <\/b> None..<br><b>K. Liu, <\/b> None..<br><b>R. Jin, <\/b> None..<br><b>T. Wang, <\/b> None..<br><b>Y. Zhang, <\/b> None..<br><b>S. Chen, <\/b> None..<br><b>Y. Gao, <\/b> None..<br><b>D. Liu, <\/b> None..<br><b>L. Yang, <\/b> None..<br><b>X. Wang, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10418","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"14","PosterboardNumber":"15","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB341","PresenterBiography":null,"PresenterDisplayName":"Jun Li, ScD","PresenterKey":"009d5bcc-4e04-4916-8885-0facfc416150","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB341. Clinical validation and mechanistic insights of ThisCART: A novel allogeneic platform enhancing CAR-T signaling via intracellular TCR&#945;&#946;\/CD3 retention","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Clinical validation and mechanistic insights of ThisCART: A novel allogeneic platform enhancing CAR-T signaling via intracellular TCR&#945;&#946;\/CD3 retention","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"Breast cancer,Immunotherapy,Antibody-drug conjugate (ADC),CAR T cells,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Z. Wu<\/b><sup>1<\/sup>, Y. Gao<sup>2<\/sup>, J. Pei<sup>1<\/sup>, E. Zhao<sup>3<\/sup>, S. Mei<sup>4<\/sup>, Y. Feng<sup>5<\/sup>, D. Zhu<sup>1<\/sup>; <br\/><sup>1<\/sup>Fudan University, Shanghai, China, <sup>2<\/sup>Zhejiang University, Zhejiang, China, <sup>3<\/sup>Shanghai Pharma, Shanghai, China, <sup>4<\/sup>Harvard Medical School, Boston, MA, <sup>5<\/sup>Zhejiang University, Hangzhou, China","CSlideId":"","ControlKey":"de27bcca-6d1f-4712-9e75-100ff2e618aa","ControlNumber":"10525","DisclosureBlock":"&nbsp;<b>Z. Wu, <\/b> None..<br><b>Y. Gao, <\/b> None..<br><b>J. Pei, <\/b> None..<br><b>E. Zhao, <\/b> None..<br><b>S. Mei, <\/b> None..<br><b>Y. Feng, <\/b> None..<br><b>D. Zhu, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10419","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"15","PosterboardNumber":"16","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB342","PresenterBiography":null,"PresenterDisplayName":"Zhongen Wu","PresenterKey":"8621c3fb-5818-419a-bb4a-8e04849edeb3","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB342. Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Potent Anti-Tumor Activity Demonstrated by Anti-AXL CAR T Cell Therapy and AXL-ADC in Lung Cancer and Breast Cancer Models","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"T cell,Melanoma\/skin cancers,Chimeric antigen receptor,Golgi,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"N. Oberholtzer<sup>1<\/sup>, P. Chakraborty<sup>1<\/sup>, M. Kassir<sup>1<\/sup>, J. Dressman<sup>1<\/sup>, Z. Hedley<sup>1<\/sup>, G. Scurti<sup>2<\/sup>, M. Gooz<sup>1<\/sup>, L. E. Ball<sup>1<\/sup>, E. Hill<sup>1<\/sup>, A. S. Mehta<sup>1<\/sup>, E. N. Maldonado<sup>1<\/sup>, M. I. Nishimura<sup>2<\/sup>, B. Ogretmen<sup>1<\/sup>, <b>S. Mehrotra<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>The Medical University of South Carolina (MUSC), Charleston, SC, <sup>2<\/sup>Loyola University, Chicago, IL","CSlideId":"","ControlKey":"b347f07b-cae1-4a97-bc08-5edaeb2117ea","ControlNumber":"10761","DisclosureBlock":"&nbsp;<b>N. Oberholtzer, <\/b> None..<br><b>P. Chakraborty, <\/b> None..<br><b>M. Kassir, <\/b> None..<br><b>J. Dressman, <\/b> None..<br><b>Z. Hedley, <\/b> None..<br><b>G. Scurti, <\/b> None..<br><b>M. Gooz, <\/b> None..<br><b>L. E. Ball, <\/b> None..<br><b>E. Hill, <\/b> None.&nbsp;<br><b>A. S. Mehta, <\/b> <br><b>GlycoPath<\/b> Grant\/Contract.<br><b>E. N. Maldonado, <\/b> None..<br><b>M. I. Nishimura, <\/b> None.&nbsp;<br><b>B. Ogretmen, <\/b> <br><b>Lipo Immuno Tech., LLC<\/b> Grant\/Contract. <br><b>S. Mehrotra, <\/b> <br><b>Lipo Immuno Tech, LLC<\/b> Grant\/Contract.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10420","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"16","PosterboardNumber":"17","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB343","PresenterBiography":null,"PresenterDisplayName":"Shikhar Mehrotra, PhD","PresenterKey":"3efa03ff-1f7b-4c39-966b-0987b1e02af3","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB343. Golgi<sup>hi<\/sup> T cells exhibit reduced susceptibility to exhaustion and improved tumor control","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Golgi<sup>hi<\/sup> T cells exhibit reduced susceptibility to exhaustion and improved tumor control","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-01 Adoptive cell therapy,,"},{"Key":"Keywords","Value":"CAR T cells,Toxicity,Gene therapy,Tumor-associated antigen (TAA),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"A. Bartlett, M. Mcwhorter, C. Collier, C. Jenkins, <b>R. Eil<\/b>; <br\/>Knight Cancer Institute, Oregon Health & Science University, Portland, OR","CSlideId":"","ControlKey":"65bf8f9a-bfc4-406d-ba66-5c29e3bad8ac","ControlNumber":"9694","DisclosureBlock":"<b>&nbsp;A. Bartlett, <\/b> <br><b>VertaBio<\/b> Stock, Patent.<br><b>M. Mcwhorter, <\/b> None..<br><b>C. Collier, <\/b> None..<br><b>C. Jenkins, <\/b> None.&nbsp;<br><b>R. Eil, <\/b> <br><b>Lyell Immunopharma<\/b> Patent, Unrelated sponsored research agreement; Consultant. <br><b>VertaBio<\/b> Stock, Patent.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10421","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"17","PosterboardNumber":"18","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB344","PresenterBiography":null,"PresenterDisplayName":"Robert Eil, MD","PresenterKey":"910f4aec-3227-47a3-91be-97e64b5f91b0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB344. A novel approach to limit off-tumor toxicity of CAR-T cells targeting solid cancers","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"A novel approach to limit off-tumor toxicity of CAR-T cells targeting solid cancers","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-06 Immune monitoring\/clinical correlates,,"},{"Key":"Keywords","Value":"Chronic lymphocytic leukemia,Immuno-oncology,Cancer markers,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>E. J. Katcher<\/b><sup>1<\/sup>, K. A. Gwin<sup>2<\/sup>, S. A. Parikh<sup>3<\/sup>, K. G. Rabe<sup>4<\/sup>, P. K. Lothert<sup>1<\/sup>, P. Trisal<sup>5<\/sup>, E. Braggio<sup>6<\/sup>, S. L. Slager<sup>4<\/sup>, N. Strong<sup>7<\/sup>, D. L. Van Dyke<sup>3<\/sup>, Z. Wang<sup>3<\/sup>, C. Huang<sup>5<\/sup>, A. K. Gandhi<sup>5<\/sup>, K. L. Medina<sup>2<\/sup>, N. E. Kay<sup>3<\/sup>; <br\/><sup>1<\/sup>Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, <sup>2<\/sup>Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, <sup>3<\/sup>Division of Hematology, Mayo Clinic, Rochester, MN, <sup>4<\/sup>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, <sup>5<\/sup>Bristol Myers Squibb, Hematology Translational Medicine, Summit, NJ, <sup>6<\/sup>Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, <sup>7<\/sup>Bristol Myers Squibb, Integrative Predictive Sciences, Summit, NJ","CSlideId":"","ControlKey":"d2a4741d-2e5a-4031-9ad6-178f431047ae","ControlNumber":"10427","DisclosureBlock":"&nbsp;<b>E. J. Katcher, <\/b> None..<br><b>K. A. Gwin, <\/b> None.&nbsp;<br><b>S. A. Parikh, <\/b> <br><b>Janssen<\/b> Other, Research funding to the institution. <br><b>AstraZeneca<\/b> Other, Research funding to the institution. <br><b>Merck<\/b> Other, Research funding to the institution. <br><b>Genentech<\/b> Other, Research funding to the institution. <br><b>Pharmacyclics<\/b> Other, Honorarium to the institution. <br><b>BeiGene<\/b> Other, Honorarium to the institution. <br><b>Amgen<\/b> Other, Honorarium to the institution. <br><b>MingSight Pharmaceuticals<\/b> Other, Honorarium to the institution. <br><b>Ascentage Pharma<\/b> Other, Honorarium to the institution. <br><b>Eli Lilly<\/b> Other, Honorarium to the institution. <br><b>TG Therapeutics<\/b> Other, Honorarium to the institution. <br><b>Novalgen Limited<\/b> Other, Honorarium to the institution. <br><b>Kite Pharma<\/b> Other, Honorarium to the institution. <br><b>AbbVie<\/b> Other, Honorarium to the institution.<br><b>K. G. Rabe, <\/b> None..<br><b>P. K. Lothert, <\/b> None.&nbsp;<br><b>P. Trisal, <\/b> <br><b>Bristol Myers Squibb<\/b> Employment.<br><b>E. Braggio, <\/b> None..<br><b>S. L. Slager, <\/b> None.&nbsp;<br><b>N. Strong, <\/b> <br><b>Bristol Myers Squibb<\/b> Employment.<br><b>D. L. Van Dyke, <\/b> None..<br><b>Z. Wang, <\/b> None.&nbsp;<br><b>C. Huang, <\/b> <br><b>Bristol Myers Squibb<\/b> Employment. <br><b>A. K. Gandhi, <\/b> <br><b>Bristol Myers Squibb<\/b> Employment.<br><b>K. L. Medina, <\/b> None.&nbsp;<br><b>N. E. Kay, <\/b> <br><b>AbbVie<\/b> Other, Advisory board and research funding. <br><b>AstraZeneca<\/b> Other, Advisory board and data safety monitoring committee (DSMC). <br><b>Beigene<\/b> Other, Advisory board. <br><b>Behring<\/b> Other, Advisory Board. <br><b>Boehringer Ingelheim Pharmaceuticals Inc.<\/b> Other, Advisory board. <br><b>Dava Oncology<\/b> Other, Advisory board. <br><b>Janssen<\/b> Other, Advisory board and DSMC. <br><b>Juno Therapeutics<\/b> Other, Advisory board. <br><b>Pharmacyclics<\/b> Other, Advisory board and research funding. <br><b>Agios Pharmaceuticals<\/b> Other, DSMC. <br><b>Bristol Myers Squibb<\/b> Other, DSMC and research funding. <br><b>Dren Bio<\/b> Other, DSMC. <br><b>Acerta Pharma<\/b> Other, Research funding. <br><b>Genentech<\/b> Other, Research funding. <br><b>Sunesis<\/b> Other, Research funding. <br><b>Vincerx<\/b> Other, Research funding.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10423","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"18","PosterboardNumber":"19","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB345","PresenterBiography":null,"PresenterDisplayName":"Ethan Katcher","PresenterKey":"53fd32da-ba4d-4b25-86aa-c00c44e1a2e2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB345. Correlating the blood immune repertoire and clinical features of del17p CLL patients","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Correlating the blood immune repertoire and clinical features of del17p CLL patients","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-07 Immune response to therapies,,"},{"Key":"Keywords","Value":"Tumor evolution,Lymphoma,CAR T cells,Immunohistochemistry,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>M. Mattie<\/b><sup>1<\/sup>, R. Perbost<sup>2<\/sup>, A. Auguste<sup>2<\/sup>, S. Turcan<sup>2<\/sup>, J. J. Kim<sup>3<\/sup>, C. To<sup>3<\/sup>, J. Nater<sup>3<\/sup>, S. Filosto<sup>3<\/sup>, R. R. Shen<sup>3<\/sup>, J. Galon<sup>4<\/sup>; <br\/><sup>1<\/sup>Kite Pharma, Inc., Santa Monica, CA, <sup>2<\/sup>Veracyte Inc., Marseille, France, <sup>3<\/sup>Kite Pharma, a Gilead company, Santa Monica, CA, <sup>4<\/sup>Veracyte, Marseille, France","CSlideId":"","ControlKey":"3288cfad-5bca-4193-b761-dd6684667c5b","ControlNumber":"10724","DisclosureBlock":"<b>&nbsp;M. Mattie, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock, Other Intellectual Property. <br><b>R. Perbost, <\/b> <br><b>Veracyte Inc.<\/b> Employment. <br><b>A. Auguste, <\/b> <br><b>Veracyte Inc.<\/b> Employment. <br><b>S. Turcan, <\/b> <br><b>Veracyte Inc.<\/b> Employment, Stock, Other Business Ownership. <br><b>J. J. Kim, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock. <br><b>C. To, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock. <br><b>J. Nater, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock Option. <br><b>S. Filosto, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock. <br><b>R. R. Shen, <\/b> <br><b>Kite Pharma, a Gilead company<\/b> Employment, Stock. <br><b>J. Galon, <\/b> <br><b>Veracyte<\/b> Stock, Other, Honoraria, consultancy\/advisory role. <br><b>Bristol Myers Squib<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Merck<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Serono<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>IO Biotech<\/b> Grant\/Contract, Other, Honoraria, consultancy\/advisory role. <br><b>Illumina<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Northwest Biotherapeutics<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Amgen<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Catalym<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Lunaphore<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Merck<\/b> Other, Honoraria, consultancy\/advisory role. <br><b>Medimmune<\/b> Grant\/Contract. <br><b>Astra Zeneca<\/b> Grant\/Contract. <br><b>Janssen<\/b> Grant\/Contract. <br><b>Imcheck Therapeutics<\/b> Grant\/Contract. <br><b>Perkin Elmer<\/b> Grant\/Contract. <br><b>INSERM<\/b> Employment, Patent, Other Intellectual Property.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10424","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"19","PosterboardNumber":"20","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB346","PresenterBiography":null,"PresenterDisplayName":"Michael Mattie, PhD","PresenterKey":"20ae192e-ee6a-44b4-ba30-b2f0fa83d90b","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB346. Dynamic changes in the tumor microenvironment from initial diagnosis through sequential therapies in patients with large B cell lymphoma undergoing axicabtagene ciloleucel (axi-cel) treatment","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Dynamic changes in the tumor microenvironment from initial diagnosis through sequential therapies in patients with large B cell lymphoma undergoing axicabtagene ciloleucel (axi-cel) treatment","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-09 Inflammation, immunity, and cancer,,"},{"Key":"Keywords","Value":"Melanoma\/skin cancers,T cell,Dendritic cells,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>H. Dhakal<\/b>, J. Zheng; <br\/>University of Louisville, Louisville, KY","CSlideId":"","ControlKey":"07b1b0ff-7a9f-41f7-8e4d-f47da7d5ed5d","ControlNumber":"9938","DisclosureBlock":"&nbsp;<b>H. Dhakal, <\/b> None..<br><b>J. Zheng, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10425","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"20","PosterboardNumber":"21","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB347","PresenterBiography":null,"PresenterDisplayName":"Hima Dhakal, PhD","PresenterKey":"a5dcfd85-acbf-4f33-8525-9518ebcda37f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB347. PLA<sub>2<\/sub>G2D\/PGD<sub>2<\/sub>-PTGDR signaling deficiency restricts the melanoma progression and lung metastasis","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"PLA<sub>2<\/sub>G2D\/PGD<sub>2<\/sub>-PTGDR signaling deficiency restricts the melanoma progression and lung metastasis","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-10 Modifiers of the tumor microenvironment,,"},{"Key":"Keywords","Value":"Tumor microenvironment,,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. Yu<\/b>, W. Park, J. Song, S. Kim, B. Park; <br\/>Y-Biologics, Daejeon, Korea, Republic of","CSlideId":"","ControlKey":"6728c0e3-6c6c-4320-96da-e8d36d445197","ControlNumber":"10595","DisclosureBlock":"&nbsp;<b>S. Yu, <\/b> None..<br><b>W. Park, <\/b> None..<br><b>J. Song, <\/b> None..<br><b>S. Kim, <\/b> None..<br><b>B. Park, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10426","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"21","PosterboardNumber":"22","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB348","PresenterBiography":null,"PresenterDisplayName":"?? ?, PhD","PresenterKey":"f177bc25-730e-4843-bd2c-4ca0cd3343ee","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB348. Discovery and in vitro efficacy validation of anti-CD39 monoclonal antibody for improving the tumor microenvironment","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discovery and in vitro efficacy validation of anti-CD39 monoclonal antibody for improving the tumor microenvironment","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-11 Therapeutic antibodies, including engineered antibodies,,"},{"Key":"Keywords","Value":"Colorectal cancer,Immuno-oncology,Antibody,Metabolism,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>J. Li<\/b><sup>1<\/sup>, K. Xia<sup>2<\/sup>, Z. Yang<sup>2<\/sup>, X. Pan<sup>1<\/sup>, X. Yang<sup>2<\/sup>, P. Wang<sup>1<\/sup>, S. Chen<sup>1<\/sup>; <br\/><sup>1<\/sup>Peking University First Hospital (Peking Univesity First Medical School), Beijing, China, <sup>2<\/sup>Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China","CSlideId":"","ControlKey":"c65c1d7e-747e-4140-8263-bcad9e018f76","ControlNumber":"9522","DisclosureBlock":"&nbsp;<b>J. Li, <\/b> None..<br><b>K. Xia, <\/b> None..<br><b>Z. Yang, <\/b> None..<br><b>X. Pan, <\/b> None..<br><b>X. Yang, <\/b> None..<br><b>P. Wang, <\/b> None..<br><b>S. Chen, <\/b> None.","End":"4\/9\/2024 5:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10427","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"22","PosterboardNumber":"23","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB349","PresenterBiography":null,"PresenterDisplayName":"Jichang Li, Dr PH","PresenterKey":"85ddae8c-5f69-4493-b545-378c5423709c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB349. Cysteine restriction enhances antitumor immunity in colorectal cancer","SearchResultFooter":"","SearchResultHeader":"Apr  9 2024  1:30PM","SessionId":"595","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 2","ShowChatLink":"false","Start":"4\/9\/2024 1:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cysteine restriction enhances antitumor immunity in colorectal cancer","Topics":null,"cSlideId":""}]